// App-Quantinova.ai

1509 : Patient Clusters Identified by Machine Learning from a Pooled Analysis of the Clinical Development Program of Secukinumab in Psoriatic Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis with Axial Manifestations

Researchers

Presenter

  • Xenofon Baraliakos

Principal Investigators

  • Effie Pournara

  • Dafna Gladman

  • Philip J Mease

  • Samad S Jahandideh

  • Laura Coates

Medical Centers

  • Rheumazentrum Ruhrgebiet, Herne, Germany

  • Novartis AG, Basel, Switzerland

  • Toronto Western Hospital, Schroeder Arthritis Institute, Toronto, Canada

  • Swedish Medical Center/Providence St. Joseph Health, Seattle, WA

  • Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences,, Oxford University Hospitals NHS Trust, Oxford, UK, Oxford, United Kingdom

Locations

  • Germany

  • Switzerland

  • Canada

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

Disease

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Dactylitis

  • Inflammatory Arthritis

  • Psoriasis

Biomarkers

  • Body mass index

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved